DUX4 suppresses MHC Class I to promote cancer immune evasion and resistance to checkpoint blockade.

The funding provided by Friends of FSH Research and the Carrino Foundation has supported Dr. Amy Campbell, a dedicated professional highly skilled in FSHD research who oversees the completion of high-impact studies on FSHD and provides scientific and technical oversight for graduate students, postdoctoral fellows, and collaborators seeking to initiate and/or advance projects in FSHD.

Amy Campbell provides a brief update of her work overseeing lab personnel, publications, etc.

Exciting new research being funded both by your investments and through our co-funding partners.